Urokinase, CX3CL1, CCL2, TRAIL and IL‐18 induced by interferon‐β treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Urokinase, CX3CL1, CCL2, TRAIL and IL‐18 induced by interferon‐β treatment

Published:2021-02-24 Issue:6 Volume:143 Page:602-607
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Zhukovsky Christina¹^ORCID,Herman Stephanie²,Wiberg Anna³,Cunningham Janet L.⁴,Kultima Kim²,Burman Joachim¹^ORCID

Affiliation:

1. Department of Neuroscience Neurology Uppsala University Uppsala Sweden

2. Department of Medical Sciences Clinical Chemistry Uppsala University Uppsala Sweden

3. Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden

4. Department of Neuroscience Psychiatry Uppsala University Uppsala Sweden

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ane.13400

Reference43 articles.

1. The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis

2. Olink. Available at. https://www.olink.com. Accessed 28 Jan.

3. HOW CELLS RESPOND TO INTERFERONS

4. Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double‐blind, placebo‐controlled trial;Duquette P;Neurology,1993

5. Interferon-β treatment for multiple sclerosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor activity of pegylated human interferon β as monotherapy or in combination with immune checkpoint inhibitors via tumor growth inhibition and dendritic cell activation;Cellular Immunology;2023-11

2. Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL;Multiple Sclerosis and Related Disorders;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3